FDA Approved: OXALIPLATIN — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Oxaliplatin from Hospira, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)